Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Byung Won Yoo"'
Autor:
Byung Hak Jin, Taegon Hong, Byung Won Yoo, Choon Ok Kim, Dasohm Kim, Youn Nam Kim, Min Soo Park
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 10, Pp n/a-n/a (2024)
Abstract Izuforant is a selective, and potent histamine H4 receptor (H4R) antagonist developed to treat atopic dermatitis (AD). There is an unmet medical need for therapeutic agents to control inflammation and pruritus. Izuforant is a strong candidat
Externí odkaz:
https://doaj.org/article/02c8d0ab346a4f9dbe60ffac452b6237
Autor:
Dasohm Kim, Minkyu Choi, Byung Hak Jin, Taegon Hong, Choon Ok Kim, Byung Won Yoo, Min Soo Park
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 8, Pp 1469-1478 (2023)
Abstract Evogliptin (EV) is a novel dipeptidyl peptidase‐4 inhibitor (DPP4i) for glycemic control in patients with type 2 diabetes mellitus (T2DM). This study evaluated the pharmacokinetic (PK) and pharmacodynamic (PD) interactions between EV and s
Externí odkaz:
https://doaj.org/article/6966ea6b7cd34023acbb8367e6fe3082
Autor:
Byung Won Yoo, Han Ki Park
Publikováno v:
Korean Journal of Pediatrics, Vol 56, Iss 6, Pp 235-241 (2013)
Repair of tetralogy of Fallot (TOF) has shown excellent outcomes. However it leaves varying degrees of residual hemodynamic impairment, with severe pulmonary stenosis (PS) and free pulmonary regurgitation (PR) at both ends of the spectrum. Since the
Externí odkaz:
https://doaj.org/article/644c8bcf85db405181cb428f8b777c70
Publikováno v:
Korean Journal of Pediatrics, Vol 54, Iss 2, Pp 86-89 (2011)
Traumatic ventricular septal defect (VSD) resulting from blunt chest injury is a very rare event. The mechanisms of traumatic VSD have been of little concern to dateuntil now, but two dominant theories have been described. In one, the rupture occurs
Externí odkaz:
https://doaj.org/article/0d4bc678b3ee419ca2905ca47cadf672
Publikováno v:
Korean Journal of Pediatrics, Vol 53, Iss 2, Pp 248-252 (2010)
Anomalous origins of coronary arteries are a rare type of disease among children. These anomalies can be categorized into 3 types according to the anatomical relationship of the aorta and pulmonary trunks. Among these types, the interarterial type, a
Externí odkaz:
https://doaj.org/article/5f518378773b45b6a03ee9deb6f1d446
Autor:
Byung Won Yoo, Han Ki Park
Publikováno v:
Korean Journal of Pediatrics, Vol 59, Iss 9, Pp 384-385 (2016)
Externí odkaz:
https://doaj.org/article/852d97a8e48a49f69400aceb1dc637d6
Autor:
Byung Won Yoo, Byung Hak Jin, Min Soo Park, Sang Hoon Ahn, Beom Kyung Kim, Dasohm Kim, Do Young Kim, Jun Yong Park, Choon Ok Kim, Taegon Hong, Jung Il Lee
Publikováno v:
British Journal of Clinical Pharmacology. 87:2757-2766
Aim Evogliptin is a potent and selective dipeptidyl peptidase-4 inhibitor for glycaemic control in patients with type 2 diabetes mellitus. Since evogliptin is mainly eliminated through hepatic metabolism, we investigated the pharmacokinetics (PKs) an
Autor:
Jean Paul Merillon, Richard A. Peace, Guy R. Heyndrickx, Peter L. M. Kerkhof, Neal Handly, Lilian J. Meijboom, Ralf W. Sprengers, Gareth Parry, Han Ki Park, Byung Won Yoo, Tatiana Kuznetsova
Publikováno v:
Kerkhof, P L M, Mérillon, J P, Yoo, B W, Peace, R A, Parry, G, Heyndrickx, G R, Kuznetsova, T, Meijboom, L J, Sprengers, R W, Park, H K & Handly, N 2018, ' The Pythagorean theorem reveals the inherent companion of cardiac ejection fraction ', International Journal of Cardiology, vol. 270, pp. 237-243 . https://doi.org/10.1016/j.ijcard.2018.06.074, https://doi.org/10.1016/j.ijcard.2018.06.074
International Journal of Cardiology, 270, 237-243. Elsevier Ireland Ltd
International Journal of Cardiology, 270, 237-243. Elsevier Ireland Ltd
BACKGROUND: Quantification of ventricular performance requires a comprehensive metric which is manageable for patient care and clinical trials. Ejection fraction (EF) has been embraced as an attractive candidate. However, being a dimensionless ratio,
Autor:
Kwang-Seok Seo, Byung Won Yoo, Taegon Hong, Min Soo Park, Byung Hak Jin, Chungam Choi, Choon Ok Kim, Ja Yun Jang
Publikováno v:
Drug Design, Development and Therapy
Chungam Choi,1 Byung Won Yoo,2 Choon Ok Kim,2 Taegon Hong,2 Byung Hak Jin,2 Kwang-Seok Seo,3 Ja Yun Jang,4 Min Soo Park2 1Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Cl
Autor:
Byung Won Yoo, Byung Hak Jin, J. M. Park, Min Soo Park, Jun Yeon Lee, Jae Soo Shin, Jung Hye Kim
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Ilaprazole, the latest proton pump inhibitor, can be used with clarithromycin and amoxicillin as a triple therapy regimen for eradicating Helicobacter pylori. The aim of this study was to evaluate pharmacokinetic drug interactions and safety